Human Gene STIM1 (ENST00000526596.2_8) from GENCODE V47lift37
  Description: stromal interaction molecule 1, transcript variant 5 (from RefSeq NM_001382567.1)
Gencode Transcript: ENST00000526596.2_8
Gencode Gene: ENSG00000167323.13_17
Transcript (Including UTRs)
   Position: hg19 chr11:3,876,894-4,114,438 Size: 237,545 Total Exon Count: 13 Strand: +
Coding Region
   Position: hg19 chr11:3,877,501-4,113,028 Size: 235,528 Coding Exon Count: 13 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr11:3,876,894-4,114,438)mRNA (may differ from genome)Protein (716 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedUniProtKB
WikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: H0YDB2_HUMAN
DESCRIPTION: SubName: Full=Stromal interaction molecule 1; Flags: Fragment;
CAUTION: The sequence shown here is derived from an Ensembl automatic analysis pipeline and should be considered as preliminary data.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: STIM1
Diseases sorted by gene-association score: myopathy, tubular aggregate, 1* (1689), immunodeficiency 10* (1678), stormorken syndrome* (1596), rhabdomyosarcoma (29), breast fibrosarcoma (16), myopathy (8), autoimmune hemolytic anemia (8), superficial mycosis (8), pityriasis versicolor (6), iris hypoplasia (6), breast sarcoma (6), rhabdoid cancer (5), autosomal dominant disease (2)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 26.21 RPKM in Esophagus - Mucosa
Total median expression: 788.99 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -288.70607-0.476 Picture PostScript Text
3' UTR -491.601410-0.349 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  Pfam Domains:
PF07647 - SAM domain (Sterile alpha motif)
PF16533 - STIM1 Orai1-activating region

SCOP Domains:
47473 - EF-hand
47769 - SAM/Pointed domain
52540 - P-loop containing nucleoside triphosphate hydrolases

ModBase Predicted Comparative 3D Structure on H0YDB2
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGDEnsembl   
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005246 calcium channel regulator activity

Biological Process:
GO:0032237 activation of store-operated calcium channel activity
GO:0051924 regulation of calcium ion transport

Cellular Component:
GO:0005783 endoplasmic reticulum
GO:0030176 integral component of endoplasmic reticulum membrane


-  Descriptions from all associated GenBank mRNAs
  U52426 - Homo sapiens GOK (STIM1) mRNA, complete cds.
HQ317451 - Homo sapiens STIM1L (STIM1) mRNA, complete cds, alternatively spliced.
BC021300 - Homo sapiens stromal interaction molecule 1, mRNA (cDNA clone MGC:29566 IMAGE:4899542), complete cds.
AK314928 - Homo sapiens cDNA, FLJ95837.
DQ895509 - Synthetic construct Homo sapiens clone IMAGE:100009969; FLH185097.01L; RZPDo839F03145D stromal interaction molecule 1 (STIM1) gene, encodes complete protein.
EU176341 - Synthetic construct Homo sapiens clone IMAGE:100006450; FLH185103.01X; RZPDo839G08251D stromal interaction molecule 1 (STIM1) gene, encodes complete protein.
JX014264 - Homo sapiens STIM1 (STIM1) mRNA, complete cds.
JD277738 - Sequence 258762 from Patent EP1572962.
JD195901 - Sequence 176925 from Patent EP1572962.
JD124947 - Sequence 105971 from Patent EP1572962.
JD392896 - Sequence 373920 from Patent EP1572962.
JD139903 - Sequence 120927 from Patent EP1572962.
JD079034 - Sequence 60058 from Patent EP1572962.
JD193335 - Sequence 174359 from Patent EP1572962.
JD261524 - Sequence 242548 from Patent EP1572962.
JD477833 - Sequence 458857 from Patent EP1572962.
HZ409492 - JP 2015528002-A/2089: CHIRAL CONTROL.
HZ459715 - WO 2015182781-A/418: Kit or device and method for detecting pancreatic cancer.
HZ460254 - WO 2015190542-A/260: Kit or device and method for detecting biliary tract cancer.
HZ462380 - WO 2015190591-A/535: Kit and method for detecting breast cancer.
HZ464542 - WO 2015194615-A/360: Kit or device and method for detecting hepatic cancer.
LG052826 - KR 1020150036642-A/2092: CHIRAL CONTROL.
LY481155 - KR 1020170010856-A/418: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY495881 - KR 1020170015509-A/260: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY498443 - KR 1020170018411-A/360: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499383 - KR 1020170018412-A/535: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LZ238809 - WO 2017171048-A/470: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS869046 - Sequence 260 from Patent EP3156500.
MS880698 - Sequence 535 from Patent EP3156498.
FR772944 - Homo sapiens microRNA hsa-miR-4687-5p.
HZ481821 - JP 2015535430-A/2327: TERMINALLY MODIFIED RNA.
HZ791752 - JP 2016504050-A/3497: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JC514484 - Sequence 4737 from Patent WO2014113089.
LF161976 - JP 2016513950-A/2042: Oligomers with improved off-target profile.
LF632621 - WO 2016117582-A/50: miRNA biomarkers for mental disorders.
LQ072072 - Sequence 2396 from Patent EP2964234.
LQ724564 - Sequence 197 from Patent WO2018096084.
JD416342 - Sequence 397366 from Patent EP1572962.
HZ459757 - WO 2015182781-A/460: Kit or device and method for detecting pancreatic cancer.
HZ460410 - WO 2015190542-A/416: Kit or device and method for detecting biliary tract cancer.
HZ462686 - WO 2015190591-A/841: Kit and method for detecting breast cancer.
HZ464776 - WO 2015194615-A/594: Kit or device and method for detecting hepatic cancer.
LY481197 - KR 1020170010856-A/460: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY496037 - KR 1020170015509-A/416: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY498677 - KR 1020170018411-A/594: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499689 - KR 1020170018412-A/841: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LZ239100 - WO 2017171048-A/761: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS869202 - Sequence 416 from Patent EP3156500.
MS881004 - Sequence 841 from Patent EP3156498.
FR772943 - Homo sapiens microRNA hsa-miR-4687-3p.
HZ459679 - WO 2015182781-A/382: Kit or device and method for detecting pancreatic cancer.
HZ460103 - WO 2015190542-A/109: Kit or device and method for detecting biliary tract cancer.
HZ462105 - WO 2015190591-A/260: Kit and method for detecting breast cancer.
HZ464324 - WO 2015194615-A/142: Kit or device and method for detecting hepatic cancer.
HZ481820 - JP 2015535430-A/2326: TERMINALLY MODIFIED RNA.
HZ791751 - JP 2016504050-A/3496: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JC514483 - Sequence 4736 from Patent WO2014113089.
LF161303 - JP 2016513950-A/1369: Oligomers with improved off-target profile.
LF632624 - WO 2016117582-A/53: miRNA biomarkers for mental disorders.
LP951625 - Sequence 131 from Patent WO2017157650.
LQ072071 - Sequence 2395 from Patent EP2964234.
LQ724841 - Sequence 474 from Patent WO2018096084.
LY481119 - KR 1020170010856-A/382: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY495730 - KR 1020170015509-A/109: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY498225 - KR 1020170018411-A/142: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499108 - KR 1020170018412-A/260: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LZ238549 - WO 2017171048-A/210: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS868895 - Sequence 109 from Patent EP3156500.
MS880423 - Sequence 260 from Patent EP3156498.
JD199911 - Sequence 180935 from Patent EP1572962.
JD519088 - Sequence 500112 from Patent EP1572962.
JD057084 - Sequence 38108 from Patent EP1572962.
MA645573 - JP 2017113010-A/3497: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA733457 - JP 2017140048-A/2327: TERMINALLY MODIFIED RNA.
MA645572 - JP 2017113010-A/3496: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA733456 - JP 2017140048-A/2326: TERMINALLY MODIFIED RNA.
MA405777 - WO 2018155427-A/551: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA406139 - WO 2018155427-A/913: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MP015183 - Sequence 386 from Patent WO2019016252.
MA806081 - WO 2018199275-A/341: Kit, device and method for detection of ovary tumor.
MA802626 - JP 2018183181-A/3497: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA805803 - WO 2018199275-A/63: Kit, device and method for detection of ovary tumor.
MA806346 - WO 2018199275-A/606: Kit, device and method for detection of ovary tumor.
MA806347 - WO 2018199275-A/607: Kit, device and method for detection of ovary tumor.
MA806516 - WO 2018199275-A/776: Kit, device and method for detection of ovary tumor.
MA802625 - JP 2018183181-A/3496: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA805969 - WO 2018199275-A/229: Kit, device and method for detection of ovary tumor.
MA822670 - WO 2019004436-A/483: Kit, device, and method for detection of lung cancer.
MA822335 - WO 2019004436-A/148: Kit, device, and method for detection of lung cancer.
MA822988 - WO 2019004436-A/801: Kit, device, and method for detection of lung cancer.
MA822986 - WO 2019004436-A/799: Kit, device, and method for detection of lung cancer.
MA822334 - WO 2019004436-A/147: Kit, device, and method for detection of lung cancer.
LY616573 - KR 1020180129785-A/470: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616864 - KR 1020180129785-A/761: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616313 - KR 1020180129785-A/210: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
MB472947 - WO 2019208671-A/346: Kit or device and method for detecting bladder cancer.
MB472948 - WO 2019208671-A/347: Kit or device and method for detecting bladder cancer.
MB472713 - WO 2019208671-A/112: Kit or device and method for detecting bladder cancer.
MB473309 - WO 2019208671-A/708: Kit or device and method for detecting bladder cancer.
MB473181 - WO 2019208671-A/580: Kit or device and method for detecting bladder cancer.
MB472712 - WO 2019208671-A/111: Kit or device and method for detecting bladder cancer.
AK098480 - Homo sapiens cDNA FLJ25614 fis, clone STM01648.
AK310510 - Homo sapiens cDNA, FLJ17552.
JD103423 - Sequence 84447 from Patent EP1572962.
JD227362 - Sequence 208386 from Patent EP1572962.
JD393511 - Sequence 374535 from Patent EP1572962.
JD548229 - Sequence 529253 from Patent EP1572962.
JD159235 - Sequence 140259 from Patent EP1572962.
JD276834 - Sequence 257858 from Patent EP1572962.
JD526998 - Sequence 508022 from Patent EP1572962.
JD365110 - Sequence 346134 from Patent EP1572962.
JD537042 - Sequence 518066 from Patent EP1572962.
JD041072 - Sequence 22096 from Patent EP1572962.
JD111924 - Sequence 92948 from Patent EP1572962.
JD325029 - Sequence 306053 from Patent EP1572962.
JD559561 - Sequence 540585 from Patent EP1572962.
JD126796 - Sequence 107820 from Patent EP1572962.
JD131759 - Sequence 112783 from Patent EP1572962.
JD117592 - Sequence 98616 from Patent EP1572962.
JD152791 - Sequence 133815 from Patent EP1572962.
JD372208 - Sequence 353232 from Patent EP1572962.
JD165083 - Sequence 146107 from Patent EP1572962.
JD161928 - Sequence 142952 from Patent EP1572962.
JD150391 - Sequence 131415 from Patent EP1572962.
JD283894 - Sequence 264918 from Patent EP1572962.
JD291335 - Sequence 272359 from Patent EP1572962.
JD544780 - Sequence 525804 from Patent EP1572962.
JD324540 - Sequence 305564 from Patent EP1572962.
JD147590 - Sequence 128614 from Patent EP1572962.
JD342648 - Sequence 323672 from Patent EP1572962.
JD207156 - Sequence 188180 from Patent EP1572962.
JD240870 - Sequence 221894 from Patent EP1572962.
JD548037 - Sequence 529061 from Patent EP1572962.
JD361321 - Sequence 342345 from Patent EP1572962.
JD209441 - Sequence 190465 from Patent EP1572962.
JD400696 - Sequence 381720 from Patent EP1572962.
JD548904 - Sequence 529928 from Patent EP1572962.
JD381893 - Sequence 362917 from Patent EP1572962.
JD327534 - Sequence 308558 from Patent EP1572962.
JD252091 - Sequence 233115 from Patent EP1572962.
JD297875 - Sequence 278899 from Patent EP1572962.
JD426445 - Sequence 407469 from Patent EP1572962.
JD340407 - Sequence 321431 from Patent EP1572962.
JD230995 - Sequence 212019 from Patent EP1572962.
JD538727 - Sequence 519751 from Patent EP1572962.
JD246025 - Sequence 227049 from Patent EP1572962.
MP330170 - Sequence 135 from Patent WO2019180153.

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000526596.1, H0YDB2, H0YDB2_HUMAN, NM_001382567, STIM1 , uc324cdo.1, uc324cdo.2
UCSC ID: ENST00000526596.2_8
RefSeq Accession: NM_001382567.1
Protein: H0YDB2

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.